The New Medicines: How Drugs are Created, Approved, Marketed, and Sold - Image 1

£41.33

Praeger The New Medicines: How Drugs are Created, Approved, Marketed, and Sold

Name: The New Medicines: How Drugs are Created, Approved, Marketed, and Sold
Brand: Praeger
Price: 41.33 GBP
Availability: InStock

3 illustrations

Law

This is the usual price. Wait for it to drop, or tell us your number.

£41 today · usual range £0–£0 · best ever £39

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 22 days • 22 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 22 days • 3 price levels

Days at Price

Current Price

Price Analysis

Most common price: £41 (14 days, 63.6%)

Price range: £39 - £44

Price levels: 3 different prices over 22 days

Description

Today, most people use prescription medications. Every year, the multi-billion dollar pharmaceutical industry produces new medicines that treat everything from arthritis to AIDS, from high cholesterol to depression. But, despite recent controversies regarding the safety of drugs, consumers know little about the medications that they ingest and inject. How are these new medicines invented? How do consumers know that drugs are safe and effective? How are they tested? Who regulates their production - and who watches the regulators? How do drug companies produce the vast quantities needed for the marketplace, and why do they market their drugs as they do? The New Medicines leads the reader through the maze of the modern drug industry - from bench to bedside - and provides consumers with a step-by-step understanding of how new medicines are created, approved, marketed, and sold. In addition to explaining how drugs reach the medicine cabinet, the author - an experienced researcher and teacher - provides the scientific and business background for understanding the current controversial issues surrounding new medicines, such as: The rise and fall of the COX-2 inhibitors, Vioxx and Celebrex, and the process by which they were invented, approved, and re-evaluated. The saga of the cancer drug Erbitux and its creator, the company Imclone, made famous as the centerpiece of the Martha Stewart insider-trading scandal. The strengths and weaknesses of the approval process of the Food and Drug Administration. The controversial new marketing techniques of the pharmaceutical industry. A balanced work that provides readers with an unbiased look at the drug industry, The New Medicines will answer the questions of anyone who has ever looked at a bottle of their prescription pills and wondered, how did that get here?

Key Features

Praeger Publishers

Product Specifications

Brand: Praeger
Model: 3 illustrations
Format: hardcover
ASIN: 027598141X
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 30 December 2005
Listed Since: 13 February 2007

Barcode

No barcode data available

Praeger The New Medicines: How Drugs are Created, Approved, Marketed, and Sold

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Edward Elgar - Intellectual Property, Pharmaceuticals and Public Health

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars Development Strategies: Fast to Market Approaches

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

How Medicines Work: Illustrated

Biosimilars and Interchangeable Biologics: Tactical Elements

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Das europäische Arzneimittelrecht: Zentrale Rechtsfragen des Arzneimittelzulassungsverfahrens

World Pharmaceutical Industry

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

An Introduction to Medicinal Chemistry

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010, Volume 1222: 77 (Annals of the New York Academy of Sciences)

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2011, Volume 1263 (Annals of the New York Academy of Sciences)

2013 U.S. Rx Company Planning Overview: Industry Trends To 2020